Skip to main content

Table 2 Echocardiographic results in patients at baseline and at the 4-year follow-up examination, and in controls

From: Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain

 

Patients, n

Patients baseline

Patients follow-up

p-value

Patients baseline vs. follow-up

Controls, n

Controls baseline

p-value

Patients baseline vs. controls

LA, mm/m2

380

20.4 (3.1)

20.6 (3.1)

ns

183

20.8 (4.0)

ns

LVEDV, mL/m2

371

46.1 (13.1)

46.5 (12.0)

< 0.05

180

48.8 (11.3)

< 0.01

LV mass, g/m2

324

101.8 (30.3)

101.7 (26.9)

ns

174

94.5 (29.9)

< 0.001

LVEF, %

370

52.0 (10.5)

53.0 (11.0)

ns

180

57.0 (9.0)

< 0.001

MAPSE, mm

370

12.0 (2.0)

12.0 (2.0)

ns

184

12.3 (2.3)

ns

E/é

378

11.9 (4.5)

13.3 (4.9)

< 0.001

183

10.3 (4.1)

< 0.001

  1. Data are presented as median and (interquartile range)
  2. LA LVEDV and LV mass are indexed by body surface area, ns not significant, LA left atrium, LVEDV left ventricular end-diastolic volume, LV left ventricle, LVEF left ventricular ejection fraction, MAPSE mitral annular plane systolic excursion, E transmitral E-wave velocity, early diastolic mitral annulus velocity